Long-term care pharmacy faced unprecedented disruptions during 2020. Patients across the entire continuum of care felt an impact in some[...]
Specialty pharmacy is the fastest growing pharmacy segment and it is estimated that specialty drugs accounted for nearly 70% of[...]
The last 20 years delivered ups and downs to long-term care (LTC) pharmacies that caused significant disruption in the M&A[...]
There are a number of factors impacting the future of the home infusion market. New reimbursement, drug shortages, PBMs, contracts[...]
There is another exciting year ahead for the long-term care (LTC) pharmacy M&A market. Before we look into the crystal[...]
The past year in specialty pharmacy was rampant with activity. On the PBM side, we saw aggressive consolidation to combat[...]
The results are in and healthcare M&A activity continues to be a strong performer in the first half of 2017.[...]
The Lower Health Care Costs Act from the Senate HELP committee will be marked up next week...
Officials say the new building will reduce operational costs by more than $60 million annually..
The expedited process and drug access would allow clinicians to complete the process..
Rule misleads patients about their out-of-pocket costs for prescription drugs
Just one subtle comment expressing workplace frustration was enough for people to view someone as a less credible health professional.